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Abstract
Mice (Mus musculus) are the most commonly used laboratory animals. Viral metagenomics on tissues of immunodeficient
mice revealed sequences of a novel mammalian astrovirus. Using PCR, we screened mice from 4 breeders, 4 pharmaceutical
companies, 14 research institutes and 30 universities in the US and Japan. Mice from one US breeder tested positive while
none from Japanese breeders were positive for MuAstV. Mice in over half of the universities (19/30), institutes (7/14) and
pharmaceutical animal facilities (2/4) investigated revealed the presence of MuAstV. Nine mice strains tested positive
including both immunodeficient strains (NSG, NOD-SCID, NSG-3GS, C57BL6-Timp-32/2, and uPA-NOG) and immunocom-
petent strains (B6J, ICR, Bash2, BALB/c). Our data indicates that MuAstV has a wide geographical, institutional and host strain
distribution. Comparison of the MuAstV RdRp sequences showed numerous mutations indicating ongoing viral divergence
in different facilities. This study demonstrates the need for metagenomic screening of laboratory animals to identify
adventitious infections that may affect experimental outcomes.
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Introduction
Mice play a significant role in biomedical research and are used
to study basic biological mechanisms, model diseases and test new
therapies [1–3]. Commercial mouse strains encompass a wide
range of genotypes and phenotypes. Various outbred and inbred
mouse strains are used in research as well as an ever-increasing
number of genetically modified strains used to study the
contribution of specific genes. For instance, numerous immuno-
compromised laboratory mouse strains have been developed that
are deficient in various components of the innate or adaptive
immune response. Severely immunodeficient mice, in particular,
have proven useful for creating in vivo models for the study of
human disease [4–7]. Elimination of the adaptive immune
response in mice allows for the engraftment of human cells and
tissues [4–7]. The resulting ‘‘humanized’’ mice serve as model
organisms for a variety of disorders and for pre-clinical research
[1,3,6,7]. Introduction of hematopoietic stem cells into immuno-
deficient mice, for example, allows for the in vivo study of their
differentiation into the various components of human blood [7–
11]. Humanized mice have aided in the development of gene
therapies and cell-based therapies for hematopoietic disorders in
humans [7,12–26].
Biomedical research using laboratory mice requires a healthy
animal colony [27]. Immunocompromised mice are especially
susceptible to infections. For example, a murine norovirus
associated with encephalitis, meningitis, hepatitis and vasculitis
was recently discovered in immunodeficient laboratory mice [28].
Such pathogens can impact biomedical research programs by
affecting research outcomes and by increasing the time and cost to
rebuild mouse colonies [27].
In order to uncover viruses circulating in laboratory mice, we
employed an approach that does not necessitate prior knowledge
of virus types. Viral metagenomics, using unbiased amplification of
enriched viral particles-associated nucleic acids and next genera-
tion sequencing provides an efficient method for characterizing the
viruses present based on sequence similarity with any previously
characterized viral genome [29–31]. This method has been
applied in the discovery of viral pathogens associated with
infections in humans, as well as in domestic and wild animals
[19,30,32–36].
We performed a viral metagenomic analysis of tissue samples
obtained from NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) immuno-
deficient mice. Following the identification of a novel astrovirus,
which was also recently described by other groups [24,37], we
used PCR and sequencing to determine the prevalence of this
virus in various mouse strains maintained at Blood Systems
Research Institute (San Francisco, CA), the Central Institute for
Experimental Animals (CIEA; Kawasaki, Japan) as well as other
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vivaria in Japan, and mice from The Jackson Laboratories (JAX;
Bar Harbor, MN and Sacramento, CA).
Materials and Methods
Sourcing and Care of Mice
The experiment in the Blood Systems Research Institute
(BSRI) was conducted with approval of the Institutional Animal
Care and Use Committee at ISIS Services LLC (San Carlos,
CA). The experiment in Japan was approved by Institutional
Animal Care and Use Committee in the Central Institute for
Experimental Animals (CIEA) based on the Regulations for
Animal Experimentation of the CIEA. For MuAstV detection in
a US breeder, immunodeficient and BALB/c mice were
ordered from Jackson Laboratory facility in Sacramento, CA.
Upon arrival, fecal samples were collected from their commer-
cial transport container. Becuase the same strain of mice
ordered from JAX was held in a single transporting container,
each container was considered as one sample to avoid over-
estimation of the viral prevalence.
All mice housed in the BSRI originated from JAX or CIEA.
Mice that have been bred or housed at BSRI are described as
originating from BSRI. The mouse vivarium at BSRI is a small
facility with access restricted to trained and authorized personnel.
Throughout this study, the vivarium operated at approximately
half of a full occupancy of 504 cages. All mice were housed in
laminar flow racks within sterile disposable microisolator cages
(Innovive Inc., San Diego, CA). All cage bedding, environmental
enrichment, food and water was radiation sterilized. All husbandry
and experimental procedures were performed within a laminar-
flow biosafety cabinet or cage-changing station. During routine
changes in caging, mice are transferred to clean cages using
forceps that are rotated through a disinfectant solution (Vimoba,
Quip Labs, Wilmington, DE) and 70% ethanol to minimize the
risk of pathogen transfer among cages. Sentinel mice exposed to
soiled bedding were used to screen for recognized murine
pathogens.
The two NSG mice used for metagenomic analysis were raised
from a colony maintained at BSRI. They were evaluated for the
presence of any underlying viral infection. By all appearance and
behavior, the animals appeared to be healthy. Histological analysis
was performed to assess the healthy status of the mice. A full
necropsy was performed and tissues were fixed in 10% buffered
formalin. The collection protocol included sections of cerebrum,
cerebellum, trigeminal nerve, skeletal muscle, salivary gland, eye,
ear, lung, heart, liver, spleen, duodenum, pancreas, jejunum,
colon, lymph nodes (peripheral, mesenteric), liver, kidney, adrenal,
and skin. Formalin-fixed tissues were processed and embedded in
paraffin, sectioned at 5 mm, and stained with hematoxylin-eosin
(H&E) for histologic evaluation.
The colony of NSG mice was founded with breeding pairs
obtained from JAX 35 months before. All other mice in the
vivarium were obtained from JAX with the exception of
breeding pairs of NOD.Cg-Prkdcscid Il2rgtm1sug Tg(Alb-Plau)11-4/
ShiJic (uPA-NOG) mice [38] obtained from CIEA and
C57BL6-Timp-32/2 obtained from the University of Texas
Health Science Center-Houston. During the last year the only
viral infection detected in the vivarium by the sentinel program
was a Murine Norovirus-1 infection associated with a colony of
C57BL6-Timp-32/2 mice, which appeared to resolve upon
rescreening several months later.
All cecum samples from mice in Japan were collected during
their microbiologic monitoring tests from Nov. to Dec. 2012. Due
to service contracts, the names of the institutes were made
anonymous, and the breeder origins of the mice were not
disclosed. Animals were euthanized by exsanguination from the
axillary artery and vein under isoflurane anesthesia. Necropsy was
then performed, and nucleic acids from the cecum samples were
extracted.
Viral Metagenomic Sequencing
Two NSG immunodeficient mice from BSRI of approximately
five weeks of age were sacrificed by CO2 asphyxiation, and their
internal organs (lung, spleen, bone marrow, liver and brain)
dissected. The organs were pooled for metagenomic analysis. Viral
purification from the pooled organs was carried out by homog-
enization, freezing and thawing, filtration and nuclease treatment
of filtrates using previously published protocols [19,31]. Viral
nucleic acids were used in reverse transcription (RT) reactions with
a primer comprising of 20-base oligonucleotide followed by a
randomized octamer sequence at the 39 end [19,31]. After
denaturation the cDNA was amplified by a single round of
DNA synthesis using Klenow fragment polymerase (New England
Biolabs). Random PCR was performed using a primer consisting
of only the 20-base fixed portion of the random primer. This
library was sequenced with 454 pyrosequencing using GS FLX+
platform. A total of 4,500 reads were generated from two animals.
Sequences were trimmed of primer sequences and those sharing at
least 95% nucleotide identities over 35 bases were assembled into
contigs. Assembled contigs and singlets were compared to the
GenBank non-redundant nucleotide and protein database using
BLASTx with an E-value cutoff of 1024 [31].
PCR and Genome Sequencing
The partial genome of the murine astrovirus BSRI (MuAstV
BSRI) was obtained by Sanger dideoxy sequencing of PCR
products obtained using combinations of primers to connect the
metagenomics-derived genome fragments. Primers were designed
using PRIMER3 [20,39]. Using the cDNA derived from the
original mice, PCRs were performed with LA Taq (Clontech)
according to the manufacturer’s instructions. PCR reactions were
carried out with a ‘‘universal touch-down PCR’’ suitable for the
melting temperatures of all primers as follows: 95uC for 5 min, 45
cycles of [94uC for 1 min, 58uC minus 0.2uC per cycle for 1 min,
72uC for 1 to 5 min], followed by 72uC for 10 min. The partial
genome was extended using 59 and 39 RACE amplification kits
(Invitrogen) according to the manufacturer’s instructions and
previously described protocols [31].
Phylogenetic Analyses
To determine the relationship of murine astrovirus BSRI to
other astroviruses, two phylograms were created based on the
nucleotide and the amino acid sequences encoded by the RNA
dependent RNA polymerase (RdRP) gene. The sequences were
aligned using Mafft 5.8 [21] with previously described parameters
[31,34]. For amino acid alignment, maximum likelihood (ML)
trees were generated from the alignment using RAxML, where
Dayhoff similarity matrix parameters were used specifying a
general time reversible model with a gamma distribution for rates
over sites [22]. ML trees were run with 100 bootstrap replications
and resulting trees were examined for consistency with published
phylogenetic trees. For nucleotide alignment, neighbor joining tree
was generated using MEGA [23] using the p-distance model with
10,000 bootstraps performed. Mid-point rooting was conducted
using MEGA [23].
Murine Astrovirus in Laboratory Mice
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Specific Reverse Transcriptase PCR (RT-PCR) for Murine
Astroviruses
RNA was extracted from mice livers and feces using the
QIAamp MinElute Virus Spin kit (Qiagen). cDNA was generated
from the sample RNA using the SuperScript III reverse
transcriptase (RT; Invitrogen) with 100 pmol of random hexamer
primer, 10 pmol of each dNTP, 10 mL of RNA, 1 mL buffer,
5 mM DTT, 1 mL of RiboLock RNase Inhibitor (Fermentas), and
200 units of RT enzyme following the manufacturer’s instruction.
To screen for MuAstV, primers MuAstV-AF (59 GCACACG-
TAGTTGGGAGTGA 39) and MuAstV-AR (59
TGGTGTGTATCCCAAGGACA 39) were used in PCR reac-
tions targeting 328 bases of the ORF1a. Sample tested positive was
re-confirmed by another PCR, using primers MuAstV-BF (59
GAATTTGACTGGACACGCTTTGA 39) and MuAstV-BR (59
GGTTTAACCCACATGCCAAA 39) targeting the RdRP, pro-
ducing an amplicon of 328 bases. The PCR reactions were carried
out using the touch-down PCR conditions described above, using
LA taq, EX taq (Clontech) or equivalent, except that the cycle
extension time used was 1 min. Amplicons were analyzed by
ethidium bromide gel electrophoresis and sequenced using Sanger
dideoxy sequencing.
Results
Viral metagenomic was performed on pooled tissues from two
NSG immunodeficient mice approximately five weeks old. All
tissues examined were histologically normal with no detectable
inflammation. An initial database search using 4500 sequence
reads using BLASTx in June 2012 indicated that nearly half of the
sequences (n = 2035) originated from a novel astrovirus with ,
60% protein sequence identity to human and porcine astroviruses.
A subsequent search with an updated GenBank database (Sep
2012) revealed the sequences were closely related to the murine
astrovirus (MuAstV) reported by two groups in late 2012 [24,37].
No other viral sequences were identified in these two laboratory
mice.
A partial genome of MuAstV-BSRI1 (Genbank Accession
KC609001), of 5274 bases was characterized using PCR and
rapid amplification of cDNA ends followed by Sanger sequencing.
MuAstV genome contained three overlapping open reading
frames (ORF1a, ORF1b, and ORF2). ORF 1a, which encodes
for protease, was partially sequenced (1354 bases). ORF1b and
ORF2, which encodes the RNA-dependent RNA polymerase
(RdRP) and capsid respectively, were completely sequenced (1351
and 2789 bases). MuAstV-BSRI1 shared 94% nucleotide identities
with the MuAstV genomes published in late 2012 by two separate
groups [24,37]. Phylogenetic analysis of the translated RdRP
sequence further confirmed that the murine astrovirus in this study
belonged to the same species as the recently described murine
astroviruses [24,37], belonging to the third genogroup of
Mammastrovirus (Fig. 1).
Using PCR, animals from multiple breeders, research institutes
and universities from the USA and Japan were screened for
MuAstV. In the USA, murine astrovirus was detected in young
adult mice shipped from the Jackson Laboratory in Sacramento,
CA and at BSRI (Table 1). Fecal samples from immunodeficient
NSG and NOD.CB17-Prkdcscid/J (NOD-SCID) mice testing
immediately upon arrival from the Jackson Laboratories tested
positive for MuAstV while feces from BALB/c mice were PCR
negative. From BSRI raised mice, MuAstV was present in the
feces of 100% (6/6) of the immunocompromised mice tested, and
0% (0/7) of the immunocompetent mice (Table 1). The absence of
MuAstV in immune-competent mice in the US might be due to
the small sample size, and that most of the mice maintained at
BSRI are adults that may have cleared their infections. Both
young and old adult immunodeficient mice tested positive for the
virus. Fecal samples from uPA-NOG mice originating from CIEA,
Japan but raised in a breeding colony at BSRI tested MuAstV
positive.
In Japan, cecum samples from laboratory mice from 3 breeders,
4 pharmaceutical companies, 13 research institutes and 30
universities were screened for MuAstV (Table 2). All three
Japanese breeders tested negative in all samples investigated.
Mice from two out of four pharmaceutical companies tested
positive for MuAstV. Seven out of thirteen research institutes
showed positive results in the MuAstV PCR tests, while murine
cecum samples from 17 out of 25 of the universities tested positive.
Laboratory mice stains testing positive in the US samples were
immunodeficient NSG, NOD-SCID, NSG-3GS, C57BL6-Timp-
32/2, and uPA-NOG mice. Stains positive in Japan were all
immunocompetent B6J, ICR, Bash2, BALB/c mice, since
immunodeficient mice investigated were from breeders and were
all negative. Higher sample size (n.10) was collected for five
mouse strains in Japan, namely B6J, BALB/c, ICR, IQI and
NOD-SCID (Table 3). MuAstV was detected in 13%, 22% and
16% of the B6J, BALB/c, ICR strains respectively. No Japanese
samples from IQI and NOD-SCID mice tested positive.
All MuAstV detected by PCR in US and Japanese laboratories
were closely related phylogenetically (Fig. 1B and C) with less than
10% nucleotide sequence divergence (Fig.1D). In contrast,
MuAstV from laboratory mice is divergent to other MuAstV
identified in wild mice [37], with sequence divergence ranging
between 26–33% (Fig. 1B and C).
Mutation sites on the laboratory mice MuAstV RdRP fragment
(321 bases) used for the diagnostic PCR were analyzed (Fig. 1D).
Synonymous mutations were frequent and, in some cases,
common mutations were seen among mice of the same strain in
the same facilities (between MuAstV USA/BSRI/NSG/1 and 2;
between MuAstV USA/BSRI/NSG/3 and 4; MuAstV USA/
CCHMC/NSG/TF18LM and 19LM) (Fig 1D). Furthermore,
mice of the same strains maintained in different facilities contained
different MuAstV mutations, for example, NSG mice in BSRI
differed from those in CCHMC. Out of the 107 codons RdRP
sequence analyzed, 8 (7.5%) non-synonymous mutation sites were
recognized (Fig. 1D). The most common NS mutations were
292Q.R and 347D.N mutations, both of which were found in
mice from the US and Japan. The 373H.L mutation only
occurred in Japan and the 375E.D mutation only in mice from
the US.
Discussion
We identified a murine astrovirus (MuAstV) using a metage-
nomic approach in pooled tissues from immunodeficient labora-
tory mice. PCR screening revealed that MuAstV is commonly
found in mice facilities in the USA and Japan, including breeding
facilities, universities and research institutes. MuAstV was detected
in a variety of mouse strains, most consistently in strains with
compromised immune systems (NSG, NOD-SCID, NSG-3GS,
C57BL6-Timp-32/2 and uPA-NOG), but also in some mouse
strains with functional immune systems (B6J, ICR, Bash2, and
BALB/c).
We also investigated MuAstV infections in facilities that
maintain both immunodeficient and immunocompetent mice,
including three Japanese breeding facilities and BSRI (Table 1 and
2). The three Japanese breeding facilities were free of MuAstV. At
BSRI, MuAstV was detected in all immunocompromised mice
Murine Astrovirus in Laboratory Mice
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Figure 1. Genome organization and phylogenetic analyses of the murine astrovirus. A) Genome organization of MuAstV. B) Phylogenetic
analysis of the translated RdRP sequence of the murine astrovirus USA/BSRI/NSG/1 and representatives of the Astroviridae using the maximum
likelihood method. C) Phylogenetic analysis of the RdRP nucleotide sequence of the murine astrovirus in laboratory mice from the USA and Japan,
along with murine astrovirus in wild and laboratory mice from the Genbank database. Sequences from wild mice were labeled with squares;
Murine Astrovirus in Laboratory Mice
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tested but none of the immunocompetent mice. A likely
explanation is that both immunodeficient and immunocompetent
mice are susceptible to MuAstV, but adaptive immunity is
required to clear the virus [24]. No inflammation was detected
in the MuAstV-positive immunodeficient NSG mice by histologic
evaluation; however, the immunodeficiency of the mice may
actually mask the inflammatory response to some degree. In
asymptomatic mice with or without immunity, Yokoyama et al
[24] detected high viral load (up to 109 genome copies per fecal
pellet). The same study detected MuAstV in liver and kidney
tissues of immunocompromised mice, but not in those internal
tissues of immunocompetent mice, suggesting MuAstV infects
immune-compromised mice systemically. Comparatively, human
astroviruses are generally associated with gastroenteritic symptoms
in patients with a weakened immune system [15,40]. For instance,
HIV-positive individuals, young children, and the elderly are
especially sensitive to enteric astrovirus infection [26,40,41].
Young children infected with human astrovirus are typically able
to clear the virus within two weeks [42]. We hypothesize that the
virus preferentially infects young mice, perhaps while still in the
nest, but that infection is then cleared only in mice with functional
immune systems.
MuAstV can clearly infect both immunocompetent and
immunodeficient mice, and its prevalence is likely to be
determined by a number of factors: 1) whether the mice were
provided by a breeder that has a history of MuAstV; 2) whether
the mice were held in a facility with other MuAstV positive mice;
and 3) whether the mice can clear the virus with a functional
immune system, and have enough time to do so (by aging). Despite
the small sample size, all immunodeficient mice in BSRI were
MuAstV positive, possibly because founder mice arrived infected
from the US breeder JAX. On the contrary, all Japanese
immunodeficient mice tested negative for MuAstV, in which the
two breeders were MuAstV-free.
MuAstV strains in laboratory mice were all closely related
(Fig. 1), including mice maintained in the USA and Japan.
Synonymous mutations occurred in all laboratory mice (Fig. 1D),
and some mutations were identical in mice of the same strain in
the same university. Certain non-synonymous mutations
(347D.N) were found in different strains in different facilities
possibly reflecting convergent evolution. We do not observe any
significant patterns in MuAstV mutations between the outbred
(ICR) or inbred derived (B6J) host strains. Since laboratory mice
are bred from existing colonies with no or limited contact with
wild mice, it is possible that the current MuAstV diversity in
laboratory mice is the result of a single, or limited, incident of
astrovirus infections in ancestral laboratory mouse populations
that has survived undetected in research facilities.
While very closely related to each other in the sequenced RdRP
region (0–9% nucleotide divergence, Fig. 1C and D), the MuAstV
sequences from laboratory mice differed from the two previously
described wild MuAstV species described in Hungary by 26–33%
and the mouse astrovirus (MoAsV) in USA by 43–45%. The three
wild mouse astroviruses were highly distinct from one another
differing in RdRP by 42–45% [37,43] (Fig. 1B and C). As was seen
with the multiple astroviruses recently identified in other host
species such as humans [44], pigs [45], and Californian sea lions
[46] it is likely that yet more astrovirus species remain to be
characterized in wild mice.
The discovery of MuAstV in laboratory mice could have
implications for research using mice, since as many as 9 strains of
laboratorymicewerepositive forMuAstVinfacilities in twocountries
and more than half of the institutes or universities investigated in this
study testedpositive forMuAstVinsomeof theirmice (Table 1and2).
For thosestrainswhere larger samplesizewastested, theprevalenceof
MuAstV ranged from 0% to 22% (Table 3). We therefore anticipate
that other mice facilities are also contaminated with MuAstV.
Although MuAstV infected immunodeficient mice showed no sign of
laboratory mice from USA with circles; laboratory mice from Japan with triangles; immunocompetent mice were labeled black and immunodeficient
mice were labeled white. D) Comparison of nucleotide sequences of MuAstV in this study with published sequences in GenBank. For each sequence,
the first row denotes nucleotides in which discrepancies were highlighted in black. The second row denotes amino acids in which discrepancies were
highlighted in color with a note – consensus amino acid was followed by the mutated amino acid and the position corresponded to the translated
ORF1b RdRP gene.
doi:10.1371/journal.pone.0066937.g001
Table 1. PCR prevalence of MuAstV in US facilities in liver and feces samples.
Sample Feces Liver
Hosting facility Strain1 Age (days) # of Positive # of Tested # of Positive # of Tested
BSRI BaLB/cJ 211/246 0 2
CByJ.B6-Tg(UBC-GFP)30Sha/J 533 0 2
C57BL/6-Tg-(UBC-GFP)30Sha/J 206/385 0 2
C57BL/6J 68/411 0 1
C57BL6-Timp-32/2 129 1 1
NSG 45/116/242 3 3
NSG-3GS 92 1 1
uPA-NOG 199–245 (pooled) 1 1
The Jackson Laboratory BaLB/cJ 44 0 1
NSG 37 1 1
NOD-SCID 37 1 1
1Strain abbreviations used: NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ (NSG-3GS), NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG), NOD.Cg-Prkdcscid
Il2rgtm1sug Tg(Alb-Plau)11-4/ShiJic (uPA-NOG), and NOD.CB17-Prkdcscid/J (NOD-SCID).
doi:10.1371/journal.pone.0066937.t001
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Table 2. PCR prevalence of MuAstV in Japanese facilities in cecum sample.
Hosting facility Strain # of Positive # of Tested Percentage Positive
Breeder A B6J 8 0%
IQI 14 0%
mdx 2 0%




Breeder C ICR 2 0%
NOD-scid 2 0%
Institute A BALB/c 1 9 11%
ICR 6 0%
Institute B B6J 1 4 25%
BALB/c6B6J 1 1 100%
Institute C ICR 5 0%
Institute D ICR 1 5 20%
Institute E ICR 1 5 20%
Institute F ICR 10 0%
Institute G ICR 5 0%
Institute H B6J 1 0%
ICR 2 7 29%
Institute I B6J 2 0%
BALB/c 3 0%
Institute J ICR 2 2 100%
Institute K ICR 1 1 100%
Institute L ICR 1 0%
Institute M unknown 1 0%
Pharmaceutical A ICR 1 2 50%
Pharmaceutical B ICR 2 0%
Pharmaceutical C BALB/c 3 9 33%
Pharmaceutical E BALB/c 1 0%
ICR 5 0%
University A ICR 5 0%
University B ICR 5 0%
University C Bach2 1 1 100%
Gfi1/CD4-cre 1 0%
ICR 1 2 50%
Menin 1 0%
University D ICR 1 5 20%
University E B6J 3 0%
ICR 3 11 27%
PKA 1 0%
University F ICR 2 7 29%
unknown 1 0%
University G ICR 2 0%
University H ICR 4 0%
University I ICR 4 0%
University J ICR 4 0%
University K ICR 2 9 22%
University L BALB/c 1 2 50%
Murine Astrovirus in Laboratory Mice
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e66937
pathology using histopathological microscopy, virus replication may
incur fitness cost and distress or otherwise affect immunological
reactions. The effects of co-infections including MuAstV are also not
known, as are the consequences of MuAstV in different immunode-
ficient strains. In studies using mice as models for cancer,
autoimmune and infectious diseases, the presence of MuAstV might
affect outcomes and the interpretation of laboratory results. Since
MuAstV infects immunocompromised mice readily and chronically
[24], it may also be useful as an animal model for the investigation of
astrovirus infections.
This study demonstrates the utility of metagenomic analyses in
identifying previously unrecognized viral infections in laboratory
animals. The same MuAstV was recently characterized in an
animal facility at the University of Cincinnati, OH, USA by
Frakas et al using a consensus PCR approach [37] and at
Washington University MO, USA by Yokoyama et al using a
metagenomics approach [24] similar to that used here in both
immunodeficient and immunocompetent laboratory mice as well
as from three commercial vendors in the USA [24] indicating a
wide distribution in North American laboratories. This study
supplements previous studies by demonstrating a wider presence of
Table 2. Cont.
Hosting facility Strain # of Positive # of Tested Percentage Positive
University M unknown 3 10 30%
University O BALB/c 1 5 20%
ICR 1 5 20%
University P ICR 3 0%
University Q ICR 6 0%
University R B6J 2 3 67%
BALB/c 1 1 100%
ICR 4 11 36%
University S B6J 1 0%
ICR 2 3 67%
University T B6J 1 0%
ICR 1 1 100%
unknown 1 1 100%
University U ICR 1 3 33%
University V B6J 2 0%
ICR 1 5 20%
University W B6J 1 0%
University X B6J 1 1 100%
B6N 1 0%
ICR 5 0%
unknown 2 3 67%
University Y ICR 1 0%
University Z B6J 1 1 100%
University AA B6J 1 0%
BALB/c 1 0%
C3H 1 1 100%
University AB C3H 1 0%
ICR 1 1 100%
University AC BALB/c 1 1 100%
University AD ICR 2 0%
University AE B6J 1 0%
ICR 1 2 50%
doi:10.1371/journal.pone.0066937.t002
Table 3. Percentage of MuAstV PCR positives in cecum
samples from five different mice strains (n.10) in Japan
facilities.
Strain # of Positive # of Tested Percentage
B6J 5 38 13%
BALB/c 8 37 22%
ICR 29 176 16%
IQI 0 14 0%
NOD-SCID 0 12 0%
doi:10.1371/journal.pone.0066937.t003
Murine Astrovirus in Laboratory Mice
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MuAstV in many strains, facilities and geographical regions (US
and Japan), and by showing viral sequence divergence in different
facilities worldwide.
While no other viral sequences were observed in the two
laboratory mice tissue virome, further studies of rodents and other
laboratory animals may reveal the presence of more unsuspected
viral infections underlining the need for continuous metagenomic
screening particularly of immunodeficient animals to ensure their
wellness as well as the accuracy and reproducibility of biomedical
research using animals.
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